Scientists Gene Hacked a Plant So It Grows Five Types of Psychoactive Drugs at Once
Could this be the world's most illegal plant? The post Scientists Gene Hacked a Plant So It Grows Five Types of Psychoactive Drugs at Once appeared first on Futurism .
In a groundbreaking scientific experiment, researchers from the Weizmann Institute of Science in Israel have genetically engineered a plant capable of producing five different psychoactive compounds simultaneously. This achievement, published in the journal Science Advances, could revolutionize the production of psychedelic substances and pave the way for more sustainable and scalable methods.
The engineered plant, a modified version of tobacco, is designed to synthesize five natural psychedelic compounds: psilocin and psilocybin, found in magic mushrooms; dimethyltryptamine (DMT), present in the ayahuasca plant; and bufotenin and 5-methoxy-DMT, which are secreted by the Sonoran Desert toad. While the potential for recreational use of this plant remains unexplored, the researchers emphasize its therapeutic potential.
Psilocybin, one of the compounds produced by the plant, has shown promise in treating mental health conditions such as depression. The ability to cultivate multiple psychedelic indolethylamines in a single organism opens up new possibilities for medical research and treatment.
The project's co-lead, Paula Berman, a postdoctoral researcher at the Weizmann Institute, stated that the primary goal is not to exploit the psychoactive properties of the plant but to explore its potential therapeutic applications. "These substances could have therapeutic potential," Berman explained to 404 Media.
The research also highlights the need for sustainable sourcing of these compounds. As interest in psychedelic substances grows for both recreational and therapeutic purposes, traditional methods of extraction from natural sources may become unsustainable. Genetically engineered plants offer a more controlled and scalable alternative.
Senior author and Weizmann Institute researcher Asaph Aharoni described the project as a "wild foray into the world of psychedelics." He noted that no one had previously attempted to combine five psychedelic compounds in a single organism. "This combination of five psychedelics—I don't think anyone has ever tried something like it," Aharoni told 404 Media.
The successful creation of this plant underscores the advancements in genetic research and the potential for harnessing the power of nature to produce complex compounds. While the immediate applications of this discovery may not be recreational, the long-term implications for medicine and sustainability are significant.
As the scientific community continues to explore the therapeutic benefits of psychedelics, the ability to produce multiple compounds in a single plant could streamline research and development. This innovative approach not only addresses the growing demand for these substances but also reduces the environmental impact associated with traditional extraction methods.
In conclusion, the Weizmann Institute's genetic engineering breakthrough represents a pioneering step in the field of psychedelic research. By creating a plant that can produce five psychoactive compounds at once, scientists are not only expanding our understanding of these substances but also laying the groundwork for more sustainable and efficient production methods. The potential for therapeutic applications, such as psilocybin-based treatments for depression, further solidifies the importance of this groundbreaking research.
